Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2023

12-02-2023 | Acute Pulmonary Embolism

Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience

Authors: Ruben Mylvaganam, Romy Lawrence, Isaac Goldberg, Farbod Rahaghi, Stephen Chiu, S. Christopher Malaisrie, Daniel Schimmel, Ryan Avery, Karlyn Martin, Michael J. Cuttica

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2023

Login to get access

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a treatable complication of acute pulmonary embolism (PE). Identification of factors that impact referral to a comprehensive CTEPH center may improve disease awareness and patient outcomes. We conducted a study of patients with acute PE. Cases were identified through a natural language processing algorithm. ICD coding was used to assess clinical documentation for dyspnea or CTEPH placed at least 90 days after their acute PE diagnosis. We analyzed characteristics of patients who were referred vs. not referred, as well as referral patterns for “at risk” patients. 2454 patients with acute PE were identified, of which 4.9% (120/2454) were referred for CTEPH evaluation. Patients who were not referred were older (61 vs. 54 years, p < 0.001), had higher rates of cancer (28% vs. 10%, p < 0.001), and lived further from the referral center (9.1 miles vs. 6.7 miles, p = 0.03). Of 175 patients identified as “at risk,” 12% (21/175) were referred. In the ‘at risk’ cohort, distance from referral center among referred and not referred was significant (5.7 miles vs. 8.8 miles, p = 0.04). There were low rates of referral to CTEPH center in post-PE patients, and in patients with symptoms who may be at higher risk of CTEPH. Age, co-morbid conditions, distance from comprehensive center, and presence of a primary care provider contribute to differences in referral to a comprehensive CTEPH center. Clinician education about CTEPH is important to ensure optimal care to patients with or at risk for chronic complications of acute PE.
Appendix
Available only for authorised users
Literature
2.
go back to reference Agarwal S, Clark III D, Sud K, Jaber WA, Cho L, Menon V (2015) Gender disparities in outcomes and resource utilization for acute pulmonary embolism hospitalizations in the United States. Am J Cardiol 116(8):1270–1276CrossRefPubMed Agarwal S, Clark III D, Sud K, Jaber WA, Cho L, Menon V (2015) Gender disparities in outcomes and resource utilization for acute pulmonary embolism hospitalizations in the United States. Am J Cardiol 116(8):1270–1276CrossRefPubMed
Metadata
Title
Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience
Authors
Ruben Mylvaganam
Romy Lawrence
Isaac Goldberg
Farbod Rahaghi
Stephen Chiu
S. Christopher Malaisrie
Daniel Schimmel
Ryan Avery
Karlyn Martin
Michael J. Cuttica
Publication date
12-02-2023

Other articles of this Issue 4/2023

Journal of Thrombosis and Thrombolysis 4/2023 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.